Sponsor Pipeline

University of Alabama at Birmingham Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-06-12
253
Active Trials
127
Recruiting
5
Phase 3
10
Disease Areas
42
Changes, 30 Days
What Changed in the Last 30 Days
DetectedTrialChange
2026-06-12 NCT07221123
Boosting Olfactory and Sensory Training Study (BOOST)
Recruitment opened
2026-06-12 NCT07221123
Boosting Olfactory and Sensory Training Study (BOOST)
Phase changed: ['EARLY_PHASE1'] -> ['PHASE2']
2026-06-12 NCT07025109
Assessing Peer Support for Physical Activity in Women With HIV and Hypertension
overall status: "Recruiting" → "Active Not Recruiting"
2026-06-12 NCT07025109
Assessing Peer Support for Physical Activity in Women With HIV and Hypertension
date change Primary completion pushed: 2026-07-31 -> 2026-08-31
2026-06-12 NCT07025109
Assessing Peer Support for Physical Activity in Women With HIV and Hypertension
date change Completion pushed: 2026-07-31 -> 2026-08-31
2026-06-10 NCT07254624
Pilot Assessment of Continuous Glucose Monitor for Post-meal Glucose Responses to Herbs…
overall status: "Recruiting" → "Active Not Recruiting"
2026-06-10 NCT04603898
Oxalate Formation From Ascorbic Acid
overall status: "Recruiting" → "Active Not Recruiting"
2026-06-10 NCT04603898
Oxalate Formation From Ascorbic Acid
Enrollment reduced: 136 -> 90 participants
2026-06-10 NCT04603898
Oxalate Formation From Ascorbic Acid
date change Primary completion pushed: 2026-08-01 -> 2026-12-01
2026-06-10 NCT04603898
Oxalate Formation From Ascorbic Acid
date change Completion pushed: 2026-12-01 -> 2027-02-01
2026-06-10 NCT07224529
Efficacy of Vevye Ophthalmic Solution for the Treatment of Meibomian Gland Dysfunction
Recruitment opened
2026-06-09 NCT07523113
ME/CFS Brain Fog: Cognitive Rehabilitation Trial
date change Primary completion pushed: 2026-04 -> 2027-06
2026-06-09 NCT07523113
ME/CFS Brain Fog: Cognitive Rehabilitation Trial
date change Completion pushed: 2028-04 -> 2028-06
2026-06-03 NCT05143840
Asciminib as Initial Therapy for Patients With Chronic Myeloid Leukemia in Chronic Phase
Sponsor changed: Augusta University -> University of Alabama at Birmingham
2026-06-03 NCT04155619
Using Early Time Restricted Feeding and Timed Light Therapy to Improve Glycemic Control…
Trial completed
2026-06-03 NCT04155619
Using Early Time Restricted Feeding and Timed Light Therapy to Improve Glycemic Control…
Enrollment reduced: 344 -> 190 participants
2026-06-03 NCT04155619
Using Early Time Restricted Feeding and Timed Light Therapy to Improve Glycemic Control…
date change Completion moved earlier: 2026-08 -> 2026-04-30
2026-06-02 NCT05434689
COMbination Regimens in MM Post AHCT to elimiNate MRD Utilizing IbERdomide
date change Primary completion pushed: 2026-04 -> 2028-08
2026-06-02 NCT05434689
COMbination Regimens in MM Post AHCT to elimiNate MRD Utilizing IbERdomide
date change Completion pushed: 2026-10 -> 2028-08
2026-06-02 NCT07102043
Glucose Metabolism in Cystic Fibrosis Related Diabetes (CFRD)
Recruitment opened
Showing 20 of 42 changes detected in the last 30 days.
New Trial Filings, Last 30 Days
First PostedTrialPhaseStatus
2026-06-09 NCT07634926 Early Time-Restricted Eating for Cardiovascular Health Not Yet Recruiting
2026-06-03 NCT07623291 Monitoring Blood Pressure at Home and Pharmacy Telehealth Not Yet Recruiting
2026-05-29 NCT07613047 Evaluating the Barrier Function, Regenerative Capacity, and Soft Tissue Outcomes of… Not Yet Recruiting
2026-05-28 NCT07611786 Development of Healthcare Transition for Patients With Congenital Adrenal Hyperplasia Not Yet Recruiting
2026-05-26 NCT07605923 Methylprednisolone Addition to Multimodal Pain Regimens After Anterior Cruciate Ligament… Phase 4 Not Yet Recruiting
2026-05-20 NCT07599852 MEDBRIDGE-Guided NCM/CHW Post-Discharge Support for High-Risk T2D Patients Not Yet Recruiting
2026-05-19 NCT07597824 DYnamic decisioN Support for IntegrAting PrEP in Clinics for Young People in Alabama and… Not Yet Recruiting
2026-05-15 NCT07589985 Hep Mec Cohort in Zambia Recruiting
Active Trials by Phase
Phase 4
11
Phase 3
4
Phase 2/3
1
Phase 2
19
Phase 1/2
10
Phase 1
9
Early Phase 1
11
Not specified
188
Active Trials — top 25 of 253
NCT IDTitleConditionStatus
Phase 4
NCT06829238 Assessment of Metformin for Restoration of Immune Homeostasis in HIV+ and HIV… Systemic Inflammation Recruiting
NCT05193552 Usage of Spirometry in Managing IgG Therapy in CVID With Airway Disease Common Variable Immunodeficiency Recruiting
NCT07135453 Induction of Cross-protective Antibodies for Serogroup 33 by Pneumococcal Conjugate… Vaccine Recruiting
NCT07224529 Efficacy of Vevye Ophthalmic Solution for the Treatment of Meibomian Gland Dysfunction Meibomian Gland Dysfunction (MGD) Recruiting
NCT06240351 A Study to Evaluate the Safety and Efficacy of Baricitinib in the Treatment of Frontal… Frontal Fibrosing Alopecia Active, Not Recruiting
NCT05566262 Bodewell Products for the Treatment of Atopic Dermatitis Atopic Dermatitis Active, Not Recruiting
NCT07457385 Congenital Syphilis Treatment Trial (CONSISTENT) in Neonates Syphilis, Congenital Not Yet Recruiting
NCT06518603 Caffeine Citrate in Preterm Infants at Risk of Apnea in Zambia Premature Infant Disease Not Yet Recruiting
NCT07485335 A Bundled Intervention to End Opioid Overdoses Opioid Use Disorder Not Yet Recruiting
NCT04101838 B Cell and Antibody Response to Seasonal Influenza Vaccines in Younger and Older Adults Influenza Active, Not Recruiting
NCT07605923 Methylprednisolone Addition to Multimodal Pain Regimens After Anterior Cruciate Ligament… ACL Reconstruction Not Yet Recruiting
Phase 3
NCT05026749 Azithromycin Treatment for Respiratory Syncytial Virus-induced Respiratory Failure in… Respiratory Syncytial Virus Infections Recruiting
NCT03912194 Early Withdrawal Exposure and Negative Affect Withdrawal (NAW) Regulation Training for… Tobacco Dependence Recruiting
NCT06902714 Effects of Oral Tranexamic Acid on Short Term Postoperative Outcomes Following Total… Shoulder Arthroplasty Recruiting
NCT04318886 Lay Coach-Led Early Palliative Care for Underserved Advanced Cancer Caregivers: The… Cancer Metastatic Active, Not Recruiting
Phase 2/3
NCT04971720 PRECISION-BP: Precision Chronopharamacotherapy Targeting NP-RAAS-BP Rhythm Axis Obesity Recruiting
Phase 2
NCT04991103 Minimal Residual Disease Response-adapted Deferral of Transplant in Dysproteinemia… Multiple Myeloma Recruiting
NCT06105684 Phase II Single Arm Trial of Low Dose Capecitabine in Patients With Advanced Breast Cancer Metastatic Breast Cancer Recruiting
NCT05664841 The Impact of a Virtual Magic Trick Training Program Autism Recruiting
NCT06599697 The MIGHT Trial - An Exploratory Clinical Trial of IVIG in Anti-HMGCR Immune Mediated… Anti-3-hydroxy-3-methylglutaryl-CoA Reductase (HMGCR) Immune-Mediated Necrotizing Myopathy Recruiting
NCT05336201 Cognitive Remediation Intervention to Prepare for Transition of Care Sickle Cell Disease Recruiting
NCT05952453 Newly Diagnosed Stage III/IV Ovarian Cancer, Neoadjuvant Carbo/Taxol/Pembro, Maintenance… Ovarian Cancer Recruiting
NCT07282886 VENTURI (VENTilation Using Respiratory Imaging) Asthma Recruiting
NCT06188741 Selumetinib for the Prevention of Plexiform Neurofibroma Growth in NF Type 1 Neurofibromatosis 1 Recruiting
NCT05143840 Asciminib as Initial Therapy for Patients With Chronic Myeloid Leukemia in Chronic Phase Chronic Myeloid Leukemia, Chronic Phase Recruiting
View all 253 active University of Alabama at Birmingham trials with filters →
Disease Areas
Get alerts when University of Alabama at Birmingham's trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free